Compare DLO & SHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DLO | SHC |
|---|---|---|
| Founded | 2013 | 2015 |
| Country | Uruguay | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 4.4B |
| IPO Year | 2021 | 2020 |
| Metric | DLO | SHC |
|---|---|---|
| Price | $13.27 | $15.28 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 7 |
| Target Price | $17.25 | ★ $20.33 |
| AVG Volume (30 Days) | 1.7M | ★ 2.6M |
| Earning Date | 05-14-2026 | 05-05-2026 |
| Dividend Yield | ★ 1.45% | N/A |
| EPS Growth | N/A | ★ 68.75 |
| EPS | N/A | ★ 0.27 |
| Revenue | N/A | ★ $1,163,617,000.00 |
| Revenue This Year | $41.00 | $7.51 |
| Revenue Next Year | $26.98 | $6.00 |
| P/E Ratio | ★ $22.27 | $57.78 |
| Revenue Growth | N/A | ★ 5.74 |
| 52 Week Low | $8.67 | $10.68 |
| 52 Week High | $16.78 | $19.85 |
| Indicator | DLO | SHC |
|---|---|---|
| Relative Strength Index (RSI) | 55.11 | 50.10 |
| Support Level | $12.98 | $15.19 |
| Resistance Level | $13.50 | $16.55 |
| Average True Range (ATR) | 0.47 | 0.39 |
| MACD | 0.01 | 0.08 |
| Stochastic Oscillator | 53.64 | 38.71 |
DLocal Ltd is focused on making the complex simple, redefining the online payment experience in emerging markets. Through its technology platform, One dLocal, the company enables world-wide enterprise merchants to get paid (pay-in) and to make payments (pay-out) online in a safe and efficient manner. The company earns revenue from fees charged to merchants in connection with payment processing services for cross-border and local payment transactions. The company operates in a single operating segment, which is payment processing. The company's geographical segments include Latin America and Non-Latin America, with a majority of its revenue being generated from Brazil in the Latin America region.
Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three reportable segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment, which generates maximum revenue, provides outsourced terminal sterilization and irradiation services for medical devices, pharmaceuticals, food safety, and other application markets using three core technologies: gamma irradiation, EO processing, and E-beam irradiation. Geographically, the company generates maximum revenue from the United States, followed by Canada, Europe, and other regions.